Literature DB >> 17175674

Pathogenesis of bacterial exacerbations of COPD.

Sateesh B Veeramachaneni1, Sanjay Sethi.   

Abstract

Acute exacerbations are significant events in the course of COPD. The pathogenesis of exacerbations was poorly understood, specifically, the role of bacteria was highly controversial. Recent observations have demonstrated that bacterial infection is involved in about half of the exacerbations. The predominant mechanism of bacterial exacerbation in COPD appears to be acquisition of new strains of bacterial pathogens from the environment that are able to establish infection in the tracheobronchial tree in COPD because of compromised innate lung defenses. These pathogens interact with airway cells, elicit an inflammatory response, which underlies the pathophysiology and symptoms characteristic of exacerbation. An immune response that can be mucosal, systemic or both develops to the infecting bacterial strain. This immune response contains the infectious process, could eradicate the infecting pathogen and prevent re-infection with the same strain. However, because of antigenic diversity among bacterial strains, this immunity tends to be strain-specific rather than widely protective. Other mechanisms, including increase in bacterial load and interaction with other etiologies such as viruses, also could contribute to bacterial exacerbations. Improved understanding of the host-pathogen interaction in the airways in COPD will lead to novel approaches to prevention and treatment of exacerbations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17175674     DOI: 10.1080/15412550600651347

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  16 in total

1.  Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.

Authors:  Christopher J Harvey; Rajesh K Thimmulappa; Sanjay Sethi; Xiaoni Kong; Lonny Yarmus; Robert H Brown; David Feller-Kopman; Robert Wise; Shyam Biswal
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

2.  Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes.

Authors:  Theodore A Omachi; Paul D Blanc; David M Claman; Hubert Chen; Edward H Yelin; Laura Julian; Patricia P Katz
Journal:  Sleep Med       Date:  2012-03-18       Impact factor: 3.492

3.  Chronic Obstructive Pulmonary Disease: Abandoning the "Streetlight Effect".

Authors:  Venkataramana K Sidhaye; Shyam Biswal
Journal:  Am J Respir Crit Care Med       Date:  2018-09-15       Impact factor: 21.405

4.  Reduced COPD Exacerbation Risk Correlates With Improved FEV1: A Meta-Regression Analysis.

Authors:  Alexander D Zider; Xiaoyan Wang; Russell G Buhr; Worawan Sirichana; Igor Z Barjaktarevic; Christopher B Cooper
Journal:  Chest       Date:  2017-05-05       Impact factor: 9.410

5.  Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype.

Authors:  Seyed Javad Moghaddam; Cecilia G Clement; M Miguelina De la Garza; Xiaoyan Zou; Elizabeth L Travis; Hays W J Young; Christopher M Evans; Michael J Tuvim; Burton F Dickey
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-20       Impact factor: 6.914

6.  Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology.

Authors:  Hoeke A Baarsma; Sophie Bos; Herman Meurs; Kim H Visser; Marieke Smit; Annemie M W J Schols; Ramon C Langen; Huib A M Kerstjens; Reinoud Gosens
Journal:  Respir Res       Date:  2013-10-23

7.  Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.

Authors:  Yusuf Aydemir; Özlem Aydemir; Fatma Kalem
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-09-27

Review 8.  Treating COPD with PDE 4 inhibitors.

Authors:  William M Brown
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 9.  Optimizing antibiotic selection in treating COPD exacerbations.

Authors:  Attiya Siddiqi; Sanjay Sethi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.

Authors:  Tetyana Zakharkina; Elke Heinzel; Rembert A Koczulla; Timm Greulich; Katharina Rentz; Josch K Pauling; Jan Baumbach; Mathias Herrmann; Christiane Grünewald; Hendrik Dienemann; Lutz von Müller; Robert Bals
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.